Market Research Media has conducted a study of Global Epidemic Influenza Preparedness Markets, their size, trends and drivers, principally for the countries with health expenditures per capita exceeding $2,000. The results of this study found that since outbreaks of bird flu in 2005 and swine flu in 2009, the governments had recognized antiviral epidemic stockpiling as their preferred strategy for disease containment and mitigation. Since that time, the role of antiviral epidemic stockpiling has migrated across all branches of the healthcare systems and sub systems. Not surprisingly, the size of antiviral pandemic stockpiling spending has grown faster than the market overall.
Market Research Media has found that over the past five years, government spending worldwide on Epidemic Influenza Preparedness has more than tripled from $2.2 billion in 2009 to $7 billion in 2019, at a 17% CAGR. Market Research Media forecasts that worldwide government spending on Epidemic Influenza Preparedness will continue to grow, though at more moderate rate of a 5% CAGR, exceeding $10 billion by 2025.
The study also identifies issues and challenges for both the government as well as drug makers in addressing this market.
